Results 281 to 290 of about 13,388,827 (299)

A case of dropped head syndrome suspected due to Dipeptidyl peptidase (DPP)-4 inhibitor use

Clinical Neurology, 2021
exaly  

DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption

Biomedicine and Pharmacotherapy, 2019
Aseel Marahleh, Hideki Kitaura, Jiawei Qi   +2 more
exaly  

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

Current Medical Research and Opinion, 2008
Avraham Karasik
exaly  

Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728

Tetrahedron, 2002
Nicolas Willand, Jurgen Joossens, Jean-Claude Gesquiere   +2 more
exaly  

The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat

European Journal of Pharmacology, 2014
Henrik H Hansen, Jacob Jelsing, Niels Vrang   +2 more
exaly  

Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes

Chinese Chemical Letters, 2010
exaly  

Cotreatment with the α-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients

Metabolism: Clinical and Experimental, 2014
Miyoko Saito, Takeshi Osonoi, Kazuki Mochizuki   +2 more
exaly  

MEDICAL USE OF A DPP-4 INHIBITOR

2015
KLEIN THOMAS, ADVANI ANDREW, CONNELLY KIM ALEXANDER, GILBERT RICHARD ERNEST   +3 more
openaire   +3 more sources

DPP-4 Inhibitors: Combination Therapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source